keyword
MENU ▼
Read by QxMD icon Read
search

Levulan

keyword
https://www.readbyqxmd.com/read/27602968/microneedling-prior-to-levulan-pdt-for-the-treatment-of-actinic-keratoses-a-split-face-blinded-trial
#1
James M Spencer, Scott A Freeman
INTRODUCTION: Photodynamic Therapy (PDT) with topical Levulan is an approved and efficacious method for treating actinic keratoses. This therapy depends on the ability of the Levulan (delta amino levulinic acid) to penetrate the stratum corneum and enter the cells of the epidermis. Microneedling is an increasing popular cosmetic therapy in which an array of tiny needles is used to make holes in the epidermis and presumably induce a wound healing cascade that leads to cosmetic improvement of the skin...
September 1, 2016: Journal of Drugs in Dermatology: JDD
https://www.readbyqxmd.com/read/26865261/toxicities-and-early-outcomes-in-a-phase-1-trial-of-photodynamic-therapy-for-premalignant-and-early-stage-head-and-neck-tumors
#2
Peter H Ahn, Harry Quon, Bert W O'Malley, Gregory Weinstein, Ara Chalian, Kelly Malloy, Joshua H Atkins, Thomas Sollecito, Martin Greenberg, Sally McNulty, Alexander Lin, Timothy C Zhu, Jarod C Finlay, Keith Cengel, Virginia Livolsi, Michael Feldman, Rosemarie Mick, Theresa M Busch
OBJECTIVES: Management of early superficial lesions in the head and neck remains complex. We performed a phase 1 trial for high-grade premalignant and early superficial lesions of the head and neck using photodynamic therapy (PDT) with Levulan (ALA). MATERIALS AND METHODS: Thirty-five subjects with high grade dysplasia, carcinoma in situ, or microinvasive (⩽1.5mm depth) squamous cell carcinoma were enrolled. Cohorts of 3-6 patients were given escalating intraoperative light doses of 50-200J/cm(2) 4-6h after oral administration of 60mg/kg ALA...
April 2016: Oral Oncology
https://www.readbyqxmd.com/read/25663047/daylight-photodynamic-therapy-the-southern-california-experience
#3
Kathryn L S Lane, Whitney Hovenic, Kaity Ball, Christopher B Zachary
BACKGROUND: Photodynamic therapy (PDT) is a safe and effective treatment for actinic keratoses (AKs) and photoactinic damage. Three elements are needed for PDT: a photosensitizer, oxygen, and a light source. Conventional PDT is performed with a variety of different laser and light sources including blue, yellow and red in addition to filtered intense pulsed lights (IPL). Daylight PDT, using ambient visible light has been reported as safe, time- and cost-efficient, and more comfortable than with other light sources...
February 2015: Lasers in Surgery and Medicine
https://www.readbyqxmd.com/read/22594990/photodynamic-therapy-of-vulvar-lichen-sclerosus-et-atrophicus-in-a-woman-with-hypothyreosis-case-report
#4
B J Osiecka, P Nockowski, K Jurczyszyn, P Ziólkowski
Lichen sclerosus et atrophicus (LSA) is disease of skin and mucosa, its pathogenesis remains unknown. Itching, pain and burning sensations and atrophy of vulva impair quality of life. Treatment is symptomatic. We report case of 30-year old woman with lesions in vulva in which series of topical PDT were carried out. We applied Levulan®Kerastick® for 4h and after that lesions were illuminated with red light. Along with above treatment patient started receiving Euthyrox®, because of recently diagnosed hypothyreosis...
June 2012: Photodiagnosis and Photodynamic Therapy
https://www.readbyqxmd.com/read/22293891/the-application-of-levulan-based-photodynamic-therapy-with-imiquimod-in-the-treatment-of-recurrent-basal-cell-carcinoma
#5
RANDOMIZED CONTROLLED TRIAL
Beata Osiecka, Kamil Jurczyszyn, Piotr Ziółkowski
BACKGROUND: Common skin tumors like basal- and squamous-cell carcinoma present a serious problem in modern medicine. Exposure to ultraviolet solar radiation is the main cause of these lesions. Since application of Aldara and PDT separately is well documented, we decided to use both methods together. The aim of our study was to evaluate the effectiveness of local photodynamic therapy supplemented with topical application of Aldara in basal-cell carcinoma. MATERIAL/METHODS: Thirty-four patients ages 50 to 68 years were enrolled to the trial and underwent PDT treatment...
February 2012: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
https://www.readbyqxmd.com/read/20232583/an-open-label-split-face-study-comparing-the-safety-and-efficacy-of-levulan-kerastick-aminolevulonic-acid-plus-a-532-nm-ktp-laser-to-a-532-nm-ktp-laser-alone-for-the-treatment-of-moderate-facial-acne
#6
RANDOMIZED CONTROLLED TRIAL
Neil Sadick
Recent advances in light therapy coupled with photosensitizers offer alternatives to topical creams and gels and systemic oral agents for acne treatment. To examine the safety and efficacy of the photosensitizer 5-aminolevulinic acid (ALA) in patients with moderate-to-severe acne, a randomized, split-face study, using ALA on one side of the face, was followed by exposure of the entire face to 532 nm potassium titanyl phosphate (KTP) laser. Eight patients completed three treatments for up to 12 weeks. The average acne grading at baseline was 3...
March 2010: Journal of Drugs in Dermatology: JDD
https://www.readbyqxmd.com/read/19125347/light-activated-cytotoxic-compounds-from-malaysian-microorganisms-for-photodynamic-therapy-of-cancer
#7
Nurkhalida Kamal, Vikineswary Sabaratnam, Noorlidah Abdullah, Anthony S H Ho, Soo H Teo, Hong B Lee
Photodynamic therapy (PDT) is a promising cancer treatment which involves activation of a photosensitizing drug with light to produce reactive oxygen species that kill tumors without causing damage to unirradiated normal tissues. To date, only Photofrin, Foscan and Levulan have been approved for clinical treatment of cancer. Tropical habitats such as those found in Malaysia are attractive sources of new therapeutic compounds as tremendous chemical diversity is found in a large number of plants, animals, marine- and micro-organisms...
February 2009: Antonie Van Leeuwenhoek
https://www.readbyqxmd.com/read/18389144/ala-and-its-clinical-impact-from-bench-to-bedside
#8
REVIEW
Barbara Krammer, Kristjan Plaetzer
ALA-induced protoporphyrin IX (PpIX) is used for fluorescence diagnosis (ALA-FD) and for fluorescence-guided resection of both (pre)malignant and non-malignant diseases. ALA is also applied in photodynamic therapy (ALA-PDT) of superficial (pre)malignant lesions in dermatology, urology, neurosurgery, otorhinolaryngology, gynecology and gastroenterology. Today, ALA is approved as Levulan for actinic keratoses, the ALA-methyl ester Metvix for actinic keratoses and basal cell carcinoma, the ALA-hexyl ester Hexvix for the diagnosis of bladder cancer and Gliolan for malignant glioma...
March 2008: Photochemical & Photobiological Sciences
https://www.readbyqxmd.com/read/17373968/photodynamic-therapy-update-2006-part-2-clinical-results
#9
REVIEW
P G Calzavara-Pinton, M Venturini, R Sala
In several randomized, controlled studies, the application of a standard preparation containing methyl-aminolevulinate (MAL; Metvix, Galderma, F), followed by red light irradiation proved effective and well tolerated in the treatment of actinic keratosis and basal cell carcinoma, and has now been approved for clinical use in European countries. A brand name aminolevulinic acid (ALA) solution (Levulan Kerastick, Dusa Pharmaceuticals Inc., Wilmington, MA) plus blue light exposure has been approved for the treatment of actinic keratosis in the USA...
April 2007: Journal of the European Academy of Dermatology and Venereology: JEADV
https://www.readbyqxmd.com/read/16788923/advances-in-photodynamic-therapy-for-the-treatment-of-head-and-neck-cancers
#10
M Biel
Photodynamic therapy (PDT) is an FDA-approved minimally invasive medical treatment modality that utilizes light in the presence of oxygen to activate photosensitizing agents that are relatively selectively concentrated in abnormal or neoplastic cells resulting in cell death. At the present time, PDT has been approved for clinical treatment in the United States, European Union, Canada, Russia, and Japan. In the United States, US Food and Drug administration approval has been given for the use of PDT in the treatment of Barrett's esophagus, obstructing esophageal carcinoma and early and obstructing tracheobronchial carcinoma using the photosensitizer Photofrin; actinic keratosis using the photosensitizer Levulan (aminolevulinic acid); and macular degeneration using the photosensitizer BPD...
June 2006: Lasers in Surgery and Medicine
https://www.readbyqxmd.com/read/16774110/henry-ford-hospital-dermatology-experience-with-levulan-kerastick-and-blue-light-photodynamic-therapy
#11
Jennifer Rivard, David Ozog
Photodynamic therapy (PDT) takes advantage of our understanding of the cutaneous response to topically applied porphyrins to selectively destroy malignant or premalignant cells. This type of therapy has been used to treat a variety of cutaneous diseases, including actinic keratoses, basal cell carcinoma, acne, and others. The treatment protocols are not standardized across institutions. We present the Henry Ford Dermatology protocol and early results of our first 150 treatments with PDT.
June 2006: Journal of Drugs in Dermatology: JDD
https://www.readbyqxmd.com/read/16699902/unilateral-basal-cell-carcinomas-an-unusual-entity-treated-with-photodynamic-therapy
#12
COMPARATIVE STUDY
Joshua E Lane, Jennifer H Allen, Tanda N Lane, Jack L Lesher
BACKGROUND: Unilateral localized basal cell carcinomas are an uncommon finding that presents both a diagnostic and therapeutic challenge. Exclusion of unilateral nevoid basal cell carcinoma syndrome is indicated. There are few reports in the literature regarding this entity and even less regarding therapeutic strategies. OBJECTIVE: We present a patient with unilateral localized basal cell carcinomas who was successfully treated with photodynamic therapy. METHODS: Photodynamic therapy was started using Levulan) Kerastick) as previously described...
December 2005: Journal of Cutaneous Medicine and Surgery
https://www.readbyqxmd.com/read/16485875/treatment-of-hyperpigmentation-melasma-with-photodynamic-therapy
#13
LindaSusan Marcus
Hyperpigmentation-melasma was treated in a 31-year-old female with the application of aminolevulinic acid HCL 20%-single use Levulan Kerastick followed by exposure to 10 J/cm2 of nonlaser blue light. The results have been excellent and long-lasting.
February 2006: Journal of Drugs in Dermatology: JDD
https://www.readbyqxmd.com/read/16485874/photodynamic-therapy-for-the-treatment-of-erythema-papules-pustules-and-severe-flushing-consistent-with-rosacea
#14
Bruce Katz, Vikas Patel
We report a case of a 45-year-old woman who presented with facial erythema, papules, pustules, and severe flushing consistent with rosacea. The patient had failed standard pharmacologic treatments. The patient's flushing was so severe that she had undergone an elective sympathectomy. She received 6 sessions of photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA as Levulan Kerastick, Dusa Pharmaceuticals) given at 2-week intervals. Improvement was evident after the second treatment and was considered "excellent" after the sixth treatment...
February 2006: Journal of Drugs in Dermatology: JDD
https://www.readbyqxmd.com/read/16485873/broad-area-photodynamic-therapy-for-treatment-of-multiple-basal-cell-carcinomas-in-a-patient-with-nevoid-basal-cell-carcinoma-syndrome
#15
Anne M Chapas, Barbara A Gilchrest
We report a case of a 73-year-old man with nevoid basal cell carcinoma syndrome who was referred to us with multiple basal cell carcinomas on his face and chest. The patient underwent photodynamic therapy utilizing a 1-hour incubation of Levulan Kerastick delta-aminolevulinic acid 20% topical solution applied to the full face and illumination with a BLU-U blue light source (10 J/cm2) every 2 to 3 months for a total of 4 treatments. This treatment strategy resulted in multiple benefits, including reducing the number and size of his existing basal cell carcinomas, improving the appearance of previous surgical scars, and decreasing the rate of tumor development...
February 2006: Journal of Drugs in Dermatology: JDD
https://www.readbyqxmd.com/read/16302560/cystic-acne-improved-by-photodynamic-therapy-with-short-contact-5-aminolevulinic-acid-and-sequential-combination-of-intense-pulsed-light-and-blue-light-activation
#16
Stuart Melnick
Photodynamic therapy with short-contact 5-aminolevulinic acid (Levulan Kerastick, Dusa Pharmaceuticals, Inc.) and activation by intense pulsed light in an initial treatment and blue light in 3 subsequent treatments has resulted in significant improvement in severity of acne, reduction in the number of lesions, improvement in skin texture, and smoothing of scar edges in an Asian patient with severe (class 4) facial cystic acne and scarring.
November 2005: Journal of Drugs in Dermatology: JDD
https://www.readbyqxmd.com/read/15989554/photodynamic-therapy-systems-and-applications
#17
Stuart L Marcus, William R McIntyre
Photodynamic therapy (PDT) is a form of photochemotherapy requiring the simultaneous presence of a photosensitiser, activating light of the proper wavelength and molecular oxygen in order to produce a localised therapeutic effect thought to be due to high-energy singlet oxygen generation. Neither drug nor light alone are effective as therapeutic agents and thus PDT treatment methods should be looked upon as true, necessary, drug and device combinations ('systems'). Selectivity of treatment is imparted by a combination of factors, including accumulation of photosensitiser by the target lesion and targeted application of activating light...
October 2002: Expert Opinion on Emerging Drugs
https://www.readbyqxmd.com/read/15841647/light-patch-preliminary-report-of-a-novel-form-of-blue-light-delivery-for-the-treatment-of-actinic-keratosis
#18
Brian Zelickson, Jeff Counters, Charlotte Coles, Mona Selim
OBJECTIVE: To evaluate a novel light patch formulated for blue light delivery and topical activation of gamma-aminolevulinic acid (ALA) during photodynamic therapy for the treatment of actinic keratosis (AK). MATERIALS AND METHODS: Ten volunteers with past unsuccessful treatment of AK were enrolled. Areas with AK lesions were treated with 20% ALA (Levulan) for an incubation period of 1 hour. Half of the area was treated with blue light patches (the patch emits 431 to 515 nm wavelength, 55...
March 2005: Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery [et Al.]
https://www.readbyqxmd.com/read/15776772/treatment-of-actinic-keratoses-with-sequential-combination-of-5-fluorouracil-and-photodynamic-therapy
#19
Dore J Gilbert
Actinic keratoses (AKs) are traditionally treated with cryotherapy, curettage, and 5-fluorouracil (5-FU, Efudex, ICN Pharmaceuticals, Inc.), all of which are associated with adverse effects. Although photodynamic therapy (PDT) with topical 5-aminolevulinic acid (ALA) offers a treatment alternative, current protocols require 14 to 18 hours incubation with ALA and patients experience pain during light treatment. Fifteen patients with multiple and diffuse facial AKs applied 5-FU nightly for 5 days and underwent PDT with ALA (Levulan Kerastick, Dusa Pharmaceuticals, Inc...
March 2005: Journal of Drugs in Dermatology: JDD
https://www.readbyqxmd.com/read/15624737/the-use-of-a-novel-intense-pulsed-light-and-heat-source-and-ala-pdt-in-the-treatment-of-moderate-to-severe-inflammatory-acne-vulgaris
#20
Michael H Gold, Virginia L Bradshaw, Molly M Boring, Tancy M Bridges, Julie A Biron, Leitha N Carter
The use of lasers and noncoherent light sources is becoming more commonplace in the treatment of inflammatory acne vulgaris. Topical 5-aminolevulinic acid (ALA) is finding its niche as an enhancer to these laser and light sources. Twenty patients with moderate to severe inflammatory acne vulgaris were enrolled in a clinical trial to evaluate the efficacy of ALA-PDT with activation by a SkinStation LHE (Radiancy, Inc., Orangeburg, NY), a novel intense pulsed light (IPL) and heat source that emits 430-nm to 1100-nm radiation at 3 to 9 J/cm2 fluences...
November 2004: Journal of Drugs in Dermatology: JDD
keyword
keyword
11192
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"